MedCity News
MARCH 26, 2025
The FDA approved GSK antibiotic Blujepa as a treatment for uncomplicated urinary tract infections. The drugs novel mechanism of action addresses a broader range of pathogens and could offer a way to lower the potential for drug resistance. The post FDA Approves First-in-Class GSK Antibiotic for Common Type of Urinary Tract Infection appeared first on MedCity News.
Evolve Your Success
MARCH 26, 2025
Want to thrive in medical sales? In this episode, TJ, a regional business director specializing in cardiology, shares insider strategies for successfrom fostering a growth mindset to mastering self-leadership. Learn how top performers refine their processes, understand their motivations, and leverage innovation to drive sales in coronary artery disease and structural heart technologies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MARCH 26, 2025
While high-acuity options must remain for those that need stronger interventions, millions more could be benefiting from access to low-acuity or minimal interventions. The post The Workforce is Suffering from Chronic Back Pain Its Time for a New Approach appeared first on MedCity News.
European Pharmaceutical Review
MARCH 26, 2025
The US Food and Drug Administration (FDA) has approved Blujepa ( gepotidacin ) antibiotic for uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients aged 12 years old and over. The first-in-class bactericidal drug is indicated for such infections caused by E scherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
MARCH 26, 2025
If marketings participation isn’t already incorporated into a company’s official product development process, theyre missing the boat. The post Marketings Untapped Opportunity in the Medical Product Lifecycle appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MARCH 26, 2025
Finalists in the Pitch Perfect contest at INVEST, scheduled for May 20-21 in Chicago at the Willis Tower, span medtech for asthma, diabetic neuropathy, Parkinson’s disease, and more. Register today! The post Check Out the Future of Medtech: A Preview of Device and Diagnostics INVEST Pitch Perfect Finalists appeared first on MedCity News.
Pharma Marketing Network
MARCH 26, 2025
Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. From generative AI tools that draft emails to predictive algorithms that segment target audiences, the speed and scale of innovation are staggering. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?
MedCity News
MARCH 26, 2025
The annual growth rate of spending for traditional drugs increased from 2.1% in 2021 to 12.8% in 2024, according to Evernorth Research Institute. The post Report: Traditional Drug Costs Outpace Specialty Due to GLP-1 Demand appeared first on MedCity News.
Clear Pivot
MARCH 26, 2025
CRMs are meant to help companies make better decisions. That said, too many of us end up drowning in dashboards that provide little value (if theyre looked at all). Reports pile up over time, often built in response to ad-hoc requests or leadership demands for more visibility. The result is what we call dashboard explosion, or in other words, a mess of half-built, rarely used, and redundant reports.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
MARCH 26, 2025
Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines
Pharmaceutical Technology
MARCH 26, 2025
Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity data.
PharmaTimes
MARCH 26, 2025
NOUS-209 shows potential to intercept cancer in its early stages
pharmaphorum
MARCH 26, 2025
The UK is providing 2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmaceutical Commerce
MARCH 26, 2025
Jen Butler, chief commercial officer, Pleio, discusses how the companys GoodStart programs help patients navigate specialty pharmacies.
Pharmaceutical Technology
MARCH 26, 2025
Multinational companies in Chinas vaccine market face headwinds amid an anti-corruption crackdown and rising competition.
Pharmaceutical Commerce
MARCH 26, 2025
The Beijing location represents the sixth worldwide.
pharmaphorum
MARCH 26, 2025
The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Commerce
MARCH 26, 2025
The latest news for pharma industry insiders.
PharmaTech
MARCH 26, 2025
The companys state-of-the-art sterile drug product manufacturing site in Saint-Beauzire, France, opened in February 2023.
Pharmaceutical Technology
MARCH 26, 2025
EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.
PharmExec
MARCH 26, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmaceutical Technology
MARCH 26, 2025
Ensuring the highest standards in pharmaceutical logistics is crucial for patient safety and treatment efficacy.
PharmExec
MARCH 26, 2025
Results from multiple clinical trials showed that Tagrisso demonstrated survival benefits in EGFR-mutated non-small cell lung cancer, both as monotherapy and in combination therapies.
Pharmaceutical Technology
MARCH 26, 2025
While Cassava is stopping investigations into simufilam in Alzheimers disease, the therapy is now being evaluated in TSC-related epilepsy.
PharmExec
MARCH 26, 2025
Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses ethical considerations surrounding AI use in medication access and how the industry can ensure that these technologies are used responsibly and equitably.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
MARCH 26, 2025
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new monthly safety bulletins aimed at making medical device and medicine safety information clearer and more accessible for healthcare professionals.
PharmExec
MARCH 26, 2025
Jennifer Kyle, CEO and founder of Condor, discusses the inspiration behind creating a financial cloud platform specifically for biopharma R&D.
Pharmaceutical Technology
MARCH 26, 2025
The FDA has approved GSKs Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and paediatric patients.
Expert insights. Personalized for you.
191 
Let's personalize your content